Sculptor Capital’s Biote Corp. Warrant BTMDW Stock Holding History

Sculptor Capital’s Portfolio BTMDW Stock Details BTMDW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-66,014	Closed	-$28.1K	–	549
2023 Q1	$28.1K	Hold	66,014	–	–	﹤0.01%	383
2022 Q4	$19.7K	Hold	66,014	–	–	﹤0.01%	609
2022 Q3	$21K	Hold	66,014	–	–	﹤0.01%	873
2022 Q2	$26K	Hold	66,014	–	–	﹤0.01%	994
2022 Q1	$37K	Hold	66,014	–	–	﹤0.01%	1121
2021 Q4	$48K	Hold	66,014	–	–	﹤0.01%	1079
2021 Q3	$54K	Hold	66,014	–	–	﹤0.01%	916
2021 Q2	$68K	Buy	+66,014	New	+$57.1K	﹤0.01%	890

Other funds holding BTMDW

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Sculptor Capital's BTMDW Position: Q2 2023 in Review

Sculptor Capital sold out of Biote Corp. Warrant (BTMDW) in Q2 2023, closing a stake of 66,014 shares — an estimated $28.1K sold.

Sculptor Capital first reported a position in BTMDW in Q2 2021 and held it in 8 quarters. The position peaked at $68K in Q2 2021. 2 funds tracked by Wall St. Rank hold BTMDW as of Q2 2023.

Sculptor Capital reported no remaining Biote Corp. Warrant position as of Q2 2023 after selling out during the quarter.
Sculptor Capital sold 66,014 Biote Corp. Warrant shares in Q2 2023, an estimated $28.1K.
Sculptor Capital first reported a position in Biote Corp. Warrant in Q2 2021 and held it in 8 quarters.
Sculptor Capital's Biote Corp. Warrant position peaked at $68K in Q2 2021.
2 funds tracked by Wall St. Rank held Biote Corp. Warrant as of Q2 2023.

Based on Sculptor Capital's 13F filing for Q2 2023, filed 14 Aug 2023.